Bond Screener
Genzyme
LEI 549300ZNNO34O8GXUE47
Organization name
Genzyme Corporation
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Genzyme Corporation, a biotechnology company, engages in the discovery and development of products and services primarily in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases, and endocrinology worldwide. Genzyme Corporation operates as a subsidiary of Sanofi.
|
General information
-
Organization nameGenzyme Corporation
-
Organization statusOperating organization
-
Address500 Kendall Street Cambridge, USA, 02142
-
Site
Stocks
General information
-
Organization nameGenzyme Corporation
-
Organization statusOperating organization
-
Address500 Kendall Street Cambridge, USA, 02142
-
Site
Codes
-
LEI549300ZNNO34O8GXUE47
-
SIC2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
-
NACE*** ***
-
NAICS*** ***
-
CIK0000732485
